You have no items in your shopping cart.
Description
Research Area
Images & Validation
−
Key Properties
−| Source | Spodoptera frugiperda, Sf 21 (baculovirus) |
|---|---|
| Expression System | Spodoptera frugiperda, Sf 21 (baculovirus) |
| Biological Activity | Measured by its ability to induce IL-17 secretion by mouse splenocytes. The ED50 for this effect is 0.05-0.3 ng/ml. |
| Molecular Weight | Apparent molecular mass of 65 kDa, 43-45 kDa and 20 kDa in SDS-PAGE under reducing conditions. |
| Purity | > 95 % by SDS-PAGE analyses. |
| Endotoxins | Less than 1.0 EU/ug of rHuIL-23 as determined by LAL method. |
Storage & Handling
−| Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
|---|---|
| Form/Appearance | Lyophilized from 0.2 μm filtered concentrated sterile solution in 20 mM MES, pH 6.0, 500 mM NaCl and 1 mM EDTA. |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Recombinant Human IL-23 Protein [orb2993911]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 19.7&34.8 KDa. Observed: 19-21&40-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Human IL-23 Protein [orb2993914]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 81.3 KDa. Observed: 80-110 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μgRecombinant Human IL-23A & mouse IL-12B Heterodimer Protein [orb2993931]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 56.9 KDa. Observed: 65-80 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μgRecombinant Human IL-23R Protein [orb2994303]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.7 KDa. Observed: 50-90 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μgRecombinant Human IL-23 Protein [orb2994028]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 55.2 KDa. Observed: 60-90 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Documents Download
Request a Document
Protocol Information
Recombinant Human Interleukin-23 (orb1906325)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review